Novel anionic surfactant-modified chlorhexidine and its potent antimicrobial properties
Viktor Dubovoy,Zilma Muneeswaran,Baran Teoman,Yu Wang,Haroon Chaudhry,Tatiana V Brinzari,Gaurav Verma,Lomaani Ranasinghe,Kylie Ryan Kaler,Xiaoyi Huang,Xing He,Belvin Thomas,Shiyou Xu,Chi-Yuan Cheng,Jeffrey M Boyd,Dailin Chen,Zhigang Hao,Shengqian Ma,Tewodros Asefa,Long Pan
DOI: https://doi.org/10.1039/d3dt02559d
IF: 4
2023-12-15
Dalton Transactions
Abstract:Chlorhexidine dodecyl sulfate (CHX-DS) was synthesized and characterized via single-crystal X-ray diffraction (SC-XRD), 1H nuclear magnetic resonance (NMR), 1H nuclear Overhauser effect spectroscopy (NOESY), and attenuated total reflectance Fourier-transform infrared spectroscopy (ATR-FTIR). The solid-state structure, comprising a 1:2 stoichiometric ratio of chlorhexidine cation [C22H30Cl2N10]2+ to dodecyl sulfate anion [C12H25SO4]-, is the first report of chlorhexidine isolated with a surfactant. CHX-DS exhibits broad-spectrum antibacterial activity and demonstrates superior efficacy to reduce bacteria-generated volatile sulfur compounds (VSCs) as compared to chlorhexidine gluconate (CHG). The minimum inhibitory concentrations (MICs) of CHX-DS is 7.5, 2.5, 2.5, and 10 μM for S. enterica, E. coli, S. aureus, and S. mutans, respectively Furthermore, MIC assays for E. coli and S. mutans demonstrate that CHX-DS and CHX exhibit a statistically significant efficacy enhancement in the 2.5 μM treatment as compared to CHG. CHX-DS was incorporated into SBA-15, a mesoporous silica nanoparticle (MSN) framework, and its release was qualitatively measured via UV-Vis in aqueous media which suggests its potential as an advanced functional material for drug delivery applications.
chemistry, inorganic & nuclear